Colgate-Palmolive (NYSE:CL) Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. lessened its stake in Colgate-Palmolive (NYSE:CLGet Rating) by 17.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,323 shares of the company’s stock after selling 9,456 shares during the quarter. Pacer Advisors Inc.’s holdings in Colgate-Palmolive were worth $3,285,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Horan Securities Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $30,000. TAP Consulting LLC purchased a new stake in Colgate-Palmolive during the 4th quarter worth approximately $40,000. Widmann Financial Services Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $42,000. Shore Point Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $43,000. Finally, Crewe Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $43,000. 78.12% of the stock is owned by institutional investors.

In other news, insider John W. Kooyman sold 19,683 shares of the business’s stock in a transaction on Monday, May 16th. The stock was sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the sale, the insider now directly owns 7,007 shares of the company’s stock, valued at $549,979.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, June 6th. The shares were sold at an average price of $79.34, for a total value of $3,967,000.00. Following the completion of the transaction, the chief executive officer now owns 221,790 shares of the company’s stock, valued at approximately $17,596,818.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 79,683 shares of company stock worth $6,297,119. 0.32% of the stock is owned by corporate insiders.

Colgate-Palmolive stock opened at $78.88 on Friday. Colgate-Palmolive has a 52 week low of $72.20 and a 52 week high of $85.61. The stock has a market cap of $66.10 billion, a price-to-earnings ratio of 32.60, a PEG ratio of 5.16 and a beta of 0.56. The company’s 50-day moving average price is $77.79 and its two-hundred day moving average price is $79.10. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 10.42.

Colgate-Palmolive (NYSE:CLGet Rating) last posted its quarterly earnings data on Friday, April 29th. The company reported $0.74 EPS for the quarter, meeting analysts’ consensus estimates of $0.74. The business had revenue of $4.40 billion for the quarter, compared to analyst estimates of $4.40 billion. Colgate-Palmolive had a net margin of 11.70% and a return on equity of 296.77%. The business’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter last year, the business earned $0.80 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.05 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has initiated a share buyback plan on Thursday, March 10th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 8.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Thursday, July 21st will be paid a dividend of $0.47 per share. The ex-dividend date is Wednesday, July 20th. This represents a $1.88 annualized dividend and a yield of 2.38%. Colgate-Palmolive’s dividend payout ratio is currently 77.69%.

Several research analysts have weighed in on CL shares. Raymond James started coverage on shares of Colgate-Palmolive in a report on Thursday, April 7th. They set a “market perform” rating for the company. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $86.00 to $81.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 30th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b” rating in a research report on Friday, April 29th. Atlantic Securities lowered Colgate-Palmolive from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $92.00 to $80.00 in a research report on Tuesday, May 3rd. Finally, The Goldman Sachs Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $95.00 in a report on Tuesday, March 29th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $83.92.

Colgate-Palmolive Profile (Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.